Complex biology, unlocked

We unite AI and cutting-edge science to discover and develop new medicines for complex diseases.


AI-generated drug pipeline

We have a proven track record of success. The Benevolent Platform™ has generated every drug programme in our pipeline, which spans from target discovery to the clinic, mixing potentially best-in-class and first-in-class drug candidates.


A diverse team passionate about building a healthier future

BenevolentAI embodies a new type of culture based on genuine collaboration between scientists and technologists who co-create the Benevolent Platform™ and work together to redefine how drugs are discovered and developed. If you are curious and collaborative and want to help shape a future of new discoveries, we would love to hear from you.